{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:26:41Z","timestamp":1791919601896,"version":"4.3.4"},"reference-count":51,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.205499","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T22:28:41Z","timestamp":1706826521000},"source":"Crossref","is-referenced-by-count":12,"title":["Prognostic model development and molecular subtypes identification in bladder urothelial cancer by oxidative stress signatures"],"prefix":"10.18632","author":[{"given":"Ying","family":"Dong","sequence":"first","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People\u2019s Hospital, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaojie","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Urology, Peking University First Hospital, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir","family":"Hameed","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Biotechnology, The Islamia University of Bahawalpur, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa A.","family":"Abdel-Maksoud","sequence":"additional","affiliation":[{"name":"Botany and Microbiology Department, College of Science, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taghreed N.","family":"Almanaa","sequence":"additional","affiliation":[{"name":"Botany and Microbiology Department, College of Science, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"Kotob","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Division of Pharmacology and Toxicology, University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wahidah H.","family":"Al-Qahtani","sequence":"additional","affiliation":[{"name":"Department of Food Sciences and Nutrition, College of Food and Agricultural Sciences, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman M.","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biology, Chemistry, Pharmacy, Free University of Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/iju.13404","article-title":"Cancer stem cells and epithelial-mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches.","volume":"2","author":"Kitamura","year":"2018","journal-title":"Int J Urol"},{"key":"2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","article-title":"Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes.","volume":"6","author":"Boorjian","year":"2016","journal-title":"Eur Urol"},{"key":"3","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/iju.13376","article-title":"Epidemiology of urothelial carcinoma.","volume":"2","author":"Nishiyama","year":"2017","journal-title":"Int J Urol"},{"key":"4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1053\/j.semnuclmed.2020.02.006","article-title":"Targets for Therapy of Bladder Cancer.","volume":"5","author":"Seidl","year":"2020","journal-title":"Semin Nucl Med"},{"key":"5","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s11255-019-02183-5","article-title":"Prediction of BCG responses in non-muscle-invasive bladder cancer in the era of novel immunotherapeutics.","volume":"5","author":"Radziszewski","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.","volume":"1","author":"Hurst","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"7","doi-asserted-by":"publisher","first-page":"866","DOI":"10.6004\/jnccn.2022.0041","article-title":"NCCN Guidelines\u00ae Insights: Bladder Cancer, Version 2.2022.","volume":"2","author":"Herr","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrc2981","article-title":"Regulation of cancer cell metabolism.","volume":"1","author":"Mak","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"9","doi-asserted-by":"publisher","first-page":"8516","DOI":"10.1074\/jbc.RA118.005953","article-title":"H2O2 induces nuclear transport of the receptor tyrosine kinase c-MET in breast cancer cells via a membrane-bound retrograde trafficking mechanism.","volume":"29","author":"Hung","year":"2019","journal-title":"J Biol Chem"},{"key":"10","doi-asserted-by":"publisher","first-page":"e2206208","DOI":"10.1002\/adma.202206208","article-title":"Catalase-Mimetic Artificial Biocatalysts with Ru Catalytic Centers for ROS Elimination and Stem-Cell Protection.","volume":"3","author":"Ye","year":"2022","journal-title":"Adv Mater"},{"key":"11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10549-015-3368-5","article-title":"Oxidative stress shapes breast cancer phenotype through chronic activation of ATM-dependent signaling.","volume":"15","author":"Brown","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"12","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nature07733","article-title":"Association of reactive oxygen species levels and radioresistance in cancer stem cells.","volume":"45","author":"Wapnir","year":"2009","journal-title":"Nature"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102201","article-title":"LRPPRC regulates redox homeostasis via the circANKHD1\/FOXM1 axis to enhance bladder urothelial carcinoma tumorigenesis.","author":"Yao","year":"2021","journal-title":"Redox Biol"},{"key":"14","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.2174\/1381612825666190215121712","article-title":"Oxidative Stress and Cancer.","volume":"2","author":"Klaunig","year":"2018","journal-title":"Curr Pharm Des"},{"key":"15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12916-023-02813-x","article-title":"Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging.","volume":"2","author":"Mohan","year":"2023","journal-title":"BMC Med"},{"key":"16","doi-asserted-by":"publisher","first-page":"9780368","DOI":"10.1155\/2022\/5220368","article-title":"Ferroptosis-Related Long Noncoding RNAs as Prognostic Marker for Colon Adenocarcinoma.","volume":"202","author":"Wu","year":"2022","journal-title":"Appl Bionics Biomech"},{"key":"17","doi-asserted-by":"publisher","first-page":"963455","DOI":"10.3389\/fmolb.2022.963455","article-title":"Clinical Eosinophil-Associated Genes can Serve as a Reliable Predictor of Bladder Urothelial Cancer.","volume":"9","author":"Kang","year":"2022","journal-title":"Front Mol Biosci"},{"key":"18","doi-asserted-by":"publisher","first-page":"6517","DOI":"10.2147\/IJGM.S335396","article-title":"A Novel Pyroptosis-Related lncRNA Signature for Predicting the Prognosis of Skin Cutaneous Melanoma.","volume":"1","author":"Shi","year":"2021","journal-title":"Int J Gen Med"},{"key":"19","doi-asserted-by":"publisher","first-page":"1047004","DOI":"10.3389\/fgene.2022.1047004","article-title":"Clinical value of M1 macrophage-related genes identification in bladder urothelial carcinoma andvalidation.","volume":"1","author":"Kang","year":"2022","journal-title":"Front Genet"},{"key":"20","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.18632\/aging.204012","article-title":"An immune subtype-related prognostic signature of hepatocellular carcinoma based on single-cell sequencing analysis.","volume":"1","author":"Wang","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"21","doi-asserted-by":"publisher","first-page":"818860","DOI":"10.3389\/fonc.2022.818860","article-title":"Identification of a Novel Tumor Microenvironment Prognostic Signature for Bladder Urothelial Carcinoma.","volume":"1","author":"Kang","year":"2022","journal-title":"Front Oncol"},{"key":"22","doi-asserted-by":"publisher","first-page":"6455704","DOI":"10.1155\/2023\/6455704","article-title":"Macrophages Phenotype Regulated by IL-6 Are Associated with the Prognosis of Platinum-Resistant Serous Ovarian Cancer: Integrated Analysis of Clinical Trial and Omics.","volume":"202","author":"Zhang","year":"2023","journal-title":"J Immunol Res"},{"key":"23","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1038\/s41375-018-0140-y","article-title":"Dysregulation of EZH2\/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS.","volume":"3","author":"Chang","year":"2018","journal-title":"Leukemia"},{"key":"24","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.2147\/OTT.S201799","article-title":"Progression of the role of CRYAB in signaling pathways and cancers.","volume":"1","author":"Yang","year":"2019","journal-title":"Onco Targets Ther"},{"key":"25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3892\/ol.2020.12356","article-title":"P4HB: A novel diagnostic and prognostic biomarker for bladder carcinoma.","volume":"2","author":"Zhou","year":"2021","journal-title":"Oncol Lett"},{"key":"26","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/modpathol.2015.56","article-title":"PDGFRA-mutant syndrome.","volume":"2","author":"Larocca","year":"2015","journal-title":"Mod Pathol"},{"key":"27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/09674845.2007.11732751","article-title":"Antioxidant status in advanced cervical cancer patients undergoing neoadjuvant chemoradiation.","volume":"6","author":"Sharma","year":"2007","journal-title":"Br J Biomed Sci"},{"key":"28","doi-asserted-by":"publisher","first-page":"623019","DOI":"10.1155\/2012\/623019","article-title":"Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis.","volume":"201","author":"Kawanishi","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"29","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1158\/0008-5472.CAN-08-3530","article-title":"A novel human AlkB homologue, ALKBH8, contributes to human bladder cancer progression.","volume":"6","author":"Konishi","year":"2009","journal-title":"Cancer Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2017.01.004","article-title":"Reactive oxygen species and cancer paradox: To promote or to suppress?","volume":"10","author":"Thayyullathil","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"31","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.urolonc.2012.02.007","article-title":"Photodynamic therapy of bladder cancer - a phase I study using hexaminolevulinate (HAL).","volume":"3","author":"Waidelich","year":"2013","journal-title":"Urol Oncol"},{"key":"32","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.omtn.2021.01.009","article-title":"Circular RNA RBPMS inhibits bladder cancer progression via miR-330-3p\/RAI2 regulation.","volume":"2","author":"Jiang","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"33","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/jjco\/hyz172","article-title":"CRYAB inhibits migration and invasion of bladder cancer cells through the PI3K\/AKT and ERK pathways.","volume":"5","author":"Liang","year":"2020","journal-title":"Jpn J Clin Oncol"},{"key":"34","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.2147\/OTT.S267734","article-title":"Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder.","volume":"1","author":"Han","year":"2020","journal-title":"Onco Targets Ther"},{"key":"35","first-page":"1150","article-title":"Urinary bladder urothelial carcinoma with expression of KIT and PDGFRA and showing diverse differentiations into plasmacytoid, clear cell, acantholytic, nested, and spindle variants, and into adenocarcinoma, signet-ring cell carcinoma, small cell carcinoma, large cell carcinoma, and pleomorphic carcinoma.","volume":"6","author":"Terada","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"36","doi-asserted-by":"publisher","first-page":"106629","DOI":"10.1016\/j.ijsu.2022.106629","article-title":"Development of a staging system and survival prediction model for advanced gastric cancer patients without adjuvant treatment after curative gastrectomy: A retrospective multicenter cohort study.","volume":"10","author":"Lee","year":"2022","journal-title":"Int J Surg"},{"key":"37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.eururo.2022.04.013","article-title":"Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder.","volume":"8","author":"Ravaud","year":"2022","journal-title":"Eur Urol"},{"key":"38","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/S0140-6736(20)30230-0","article-title":"Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial.","volume":"39","author":"\u00d6zg\u00fcro\u011flu","year":"2020","journal-title":"Lancet"},{"key":"39","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.","volume":"38","author":"Enting","year":"2021","journal-title":"N Engl J Med"},{"key":"40","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1038\/s41591-021-01579-0","article-title":"Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial.","volume":"2","author":"Aarts","year":"2021","journal-title":"Nat Med"},{"key":"41","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S1470-2045(21)00152-2","article-title":"Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.","volume":"2","author":"Loriot","year":"2021","journal-title":"Lancet Oncol"},{"key":"42","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1470-2045(21)00147-9","article-title":"Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study.","volume":"2","author":"Konety","year":"2021","journal-title":"Lancet Oncol"},{"key":"43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.freeradbiomed.2021.05.009","article-title":"Verification of ferroptosis and pyroptosis and identification of PTGS2 as the hub gene in human coronary artery atherosclerosis.","volume":"17","author":"Jia","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"44","doi-asserted-by":"publisher","first-page":"29480","DOI":"10.18632\/oncotarget.8784","article-title":"B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy.","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"45","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/s41591-020-1086-y","article-title":"Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma.","volume":"2","author":"Corn","year":"2020","journal-title":"Nat Med"},{"key":"46","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/s41591-020-1085-z","article-title":"Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial.","volume":"2","author":"Lubeck","year":"2020","journal-title":"Nat Med"},{"key":"47","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3892\/ijo_00000285","article-title":"Differential effects of MAPKs signaling on the growth of invasive bladder cancer cells.","volume":"3","author":"Koul","year":"2009","journal-title":"Int J Oncol"},{"key":"48","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1158\/0008-5472.CAN-09-2918","article-title":"p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity.","volume":"7","author":"Koul","year":"2010","journal-title":"Cancer Res"},{"key":"49","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.3390\/ijms23105319","article-title":"Wnt\/\u03b2-Catenin Signalling and Its Cofactor BCL9L Have an Oncogenic Effect in Bladder Cancer Cells.","volume":"2","author":"Steinbach","year":"2022","journal-title":"Int J Mol Sci"},{"key":"50","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.2147\/IJGM.S348945","article-title":"An Oxidative Stress-Related Genes Signature for Predicting Survival in Bladder Cancer: Based on TCGA Database and Bioinformatics.","volume":"1","author":"Tang","year":"2022","journal-title":"Int J Gen Med"},{"key":"51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data.","volume":"1","author":"Guinney","year":"2013","journal-title":"BMC Bioinformatics"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T22:28:44Z","timestamp":1706826524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":51,"alternative-id":["205499"],"URL":"https:\/\/doi.org\/10.18632\/aging.205499","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}